{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:49:33Z","timestamp":1787032173573,"version":"build-2736575974"},"reference-count":27,"publisher":"Societas Neurologica Japonica","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.205","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T19:03:05Z","timestamp":1363978985000},"page":"205-211","source":"Crossref","is-referenced-by-count":4,"title":["A case of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis with multiple mitochondrial DNA deletions"],"prefix":"10.5692","volume":"53","author":[{"given":"Koji","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutoshi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Ohyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyo","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Johns DR. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. N Engl J Med 1995;333:638-644.","DOI":"10.1056\/NEJM199509073331007"},{"key":"2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283:1482-1488.","DOI":"10.1126\/science.283.5407.1482"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fadic R, Russell JA, Vedanarayanan VV, et al. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 1997;49:239-245.","DOI":"10.1212\/WNL.49.1.239"},{"key":"5","unstructured":"5) Holt IJ, Harding AE, Petty RKH, et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-433."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-727.","DOI":"10.1212\/WNL.44.4.721"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Zeviani M, Servidei S, Gellera C, et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989;339:309-311.","DOI":"10.1038\/339309a0"},{"key":"8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Van Goethem G, Luoma P, Rantamaki M, et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 2004;63:1251-1257.","DOI":"10.1212\/01.WNL.0000140494.58732.83"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) H\u00fcbner G, Gokel JM, Pongratz D, et al. Fatal mitochondrial cardiomyopathy in Kearns-Sayre syndrome. Virchows Arch A Pathol Anat Histopathol 1986;408:611-621.","DOI":"10.1007\/BF00705340"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Schwartzkopff B, Frenzel H, Breithardt G, et al. Ultrastructural findings in endomyocardial biopsy of patients with Kearns-Sayre syndrome. J Am Coll Cardiol 1988;12:1522-1528.","DOI":"10.1016\/S0735-1097(88)80020-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Polak PE, Zijlstra F, Roelandt JRTC. Indications for pacemaker implantation in the Kearns-Sayre syndrome. Eur Heart J 1989;10:281-282.","DOI":"10.1093\/oxfordjournals.eurheartj.a059477"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Spinazzola A, Invernizzi F, Carrara F, et al. Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 2009;32:143-158.","DOI":"10.1007\/s10545-008-1038-z"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Copeland WC. Inherited mitochondrial diseases of DNA replication. Annu Rev Med 2008;59:131-146.","DOI":"10.1146\/annurev.med.59.053006.104646"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Van Goethem G, Martin JJ, Dermaut B, et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003;13:133-142.","DOI":"10.1016\/S0960-8966(02)00216-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Di Fonzo A, Bordoni A, Crimi M, et al. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions. Hum Mutat 2003;22:498-499.","DOI":"10.1002\/humu.9203"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mancuso M, Filosto M, Bellan M, et al. POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness. Neurology 2004;62:316-318.","DOI":"10.1212\/WNL.62.2.316"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Na\u00efmi M, Bannwarth S, Procaccio V, et al. Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple deletions or depletion of mitochondrial DNA by a dHPLC-based assay. Eur J Hum Genet 2006;14:917-922.","DOI":"10.1038\/sj.ejhg.5201627"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gago MF, Rosas MJ, Guimar\u00e3es J, et al. SANDO: two novel mutations in POLG1 gene. Neuromuscul Disord 2006;16:507-509.","DOI":"10.1016\/j.nmd.2006.05.016"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Milone M, Brunetti-Pierri N, Tang LY, et al. Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord 2008;18:626-632.","DOI":"10.1016\/j.nmd.2008.05.009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hudson G, Deschauer M, Busse K, et al. Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism. Neurology 2005;64:371-373.","DOI":"10.1212\/01.WNL.0000149767.51152.83"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Longley MJ, Clark S, Yu Wai Man C, et al. Mutant POLG2 disrupts DNA polymerase g subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006;78:1026-1034.","DOI":"10.1086\/504303"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000;289:782-785.","DOI":"10.1126\/science.289.5480.782"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Agostino A, Valletta L, Chinnery PF, et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003;60:1354-1356.","DOI":"10.1212\/01.WNL.0000056088.09408.3C"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Niemann A, Ruegg M, La Padula V, et al. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 2005;170:1067-1078.","DOI":"10.1083\/jcb.200507087"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Baloh RH, Schmidt RE, Pestronk A, et al. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci 2007;27:422-430.","DOI":"10.1523\/JNEUROSCI.4798-06.2007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Okun MS, Bhatti MT. SANDO: another presentation of mitochondrial disease. Am J Ophthalmol 2004;137:951-953.","DOI":"10.1016\/j.ajo.2003.10.046"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2DNA\u306b\u591a\u91cd\u6b20\u5931\u3092\u307f\u3068\u3081\u305fsensory ataxic neuropathy, dysarthria, and ophthalmoparesis\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T16:06:23Z","timestamp":1621526783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/53\/3\/53_205\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.205","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}